linagliptin and metformin hydrochloride
Generic: linagliptin and metformin hydrochloride
Labeler: novadoz pharmaceuticals llcDrug Facts
Product Profile
Brand Name
linagliptin and metformin hydrochloride
Generic Name
linagliptin and metformin hydrochloride
Labeler
novadoz pharmaceuticals llc
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
linagliptin 2.5 mg/1, metformin hydrochloride 500 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72205-407
Product ID
72205-407_5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA208459
Listing Expiration
2026-12-31
Marketing Start
2025-11-03
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72205407
Hyphenated Format
72205-407
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
linagliptin and metformin hydrochloride (source: ndc)
Generic Name
linagliptin and metformin hydrochloride (source: ndc)
Application Number
ANDA208459 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2.5 mg/1
- 500 mg/1
Packaging
- 60 TABLET, FILM COATED in 1 BOTTLE (72205-407-01)
- 180 TABLET, FILM COATED in 1 BOTTLE (72205-407-02)
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb", "openfda": {"nui": ["N0000175912", "N0000175913"], "upc": ["0372205408029", "0372205407015", "0372205409019", "0372205407022", "0372205409026", "0372205408012"], "unii": ["3X29ZEJ4R2", "786Z46389E"], "rxcui": ["1243020", "1243027", "1243034"], "spl_set_id": ["5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb"], "pharm_class_epc": ["Dipeptidyl Peptidase 4 Inhibitor [EPC]"], "pharm_class_moa": ["Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (72205-407-01)", "package_ndc": "72205-407-01", "marketing_start_date": "20251104"}, {"sample": false, "description": "180 TABLET, FILM COATED in 1 BOTTLE (72205-407-02)", "package_ndc": "72205-407-02", "marketing_start_date": "20251104"}], "brand_name": "Linagliptin and metformin hydrochloride", "product_id": "72205-407_5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Biguanide [EPC]", "Biguanides [CS]", "Dipeptidyl Peptidase 4 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "product_ndc": "72205-407", "generic_name": "Linagliptin and metformin hydrochloride", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Linagliptin and metformin hydrochloride", "active_ingredients": [{"name": "LINAGLIPTIN", "strength": "2.5 mg/1"}, {"name": "METFORMIN HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA208459", "marketing_category": "ANDA", "marketing_start_date": "20251103", "listing_expiration_date": "20261231"}